Vice Chair of Immunology at TSRI joins SAB

Vice Chairman of Immunology at The Scripps Research Institute to Assist with ValloVax™ Clinical Development

Argyrios Theofilopoulos, MD, Joins Batu’s Scientific Advisory Board

Batu Biologics, an immuno-oncology company dedicated to the development of its tumor-angiogenesis targeting immune therapy, ValloVax™, announced today the appointment of Argyrios Theofilopoulos, MD of The Scripps Research Institute to its scientific advisory board.

Read the full article at